One Nucleus serves to bring attention, insight and connectivity to potential growth and collaboration opportunities for its members and wider network. An example has arisen with a visit to the UK of a high-level delegation from South Carolina which includes James Chappell, CEO SCBIO, Philip Morgan, South Carolina Dept of Commerce and Aimee Redick, Upstate Alliance.
Recent investments and expansions by leading biotechnology and pharmaceutical companies have brought recognition to South Carolina as a top destination for life sciences industry companies. With a talented and innovative workforce, top research institutions and world-class hospital systems, the Palmetto State boasts an expanding biotech infrastructure. With such exceptional assets, a dynamic group of bulk manufacturers, chemical processors, generic and proprietary pharmaceutical developers, hygiene product producers and packagers and related research and development companies have all decided to make their home in South Carolina. As a result, the Palmetto State has cultivated a truly cutting-edge life science sector. These characteristics lend themselves well to Cambridge and UK life science companies in biopharma, medical devices, digital health and more exploring possible growth and collaboration opportunities in the US where South Carolina may be the best partner.
For more information and to register, click here.
